Albuterol

• 

  Subject Areas on Research

  • Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. 
  • Airway smooth muscle dysfunction in Pompe (Gaa-/- ) mice. 
  • Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids. 
  • An Asthma Protocol Improved Adherence to Evidence-Based Guidelines for Pediatric Subjects With Status Asthmaticus in the Emergency Department. 
  • Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. 
  • Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. 
  • Bronchiolitis. 
  • Childhood asthma clusters and response to therapy in clinical trials. 
  • Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. 
  • Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. 
  • Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma. 
  • Contamination of nebulizer equipment with cockroach allergen: there's a bug in the system! 
  • Dispensing home nebulizers for acute wheezing from the hospital is cost-effective. 
  • Early management of acute severe asthma. 
  • Editorial: Selectivity in beta-adrenergic responses: clinical implications. 
  • Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. 
  • Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. 
  • Enterovirus D68 Infection in an Adult. 
  • GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. 
  • Impact of race on asthma treatment failures in the asthma clinical research network. 
  • Individualized therapy for persistent asthma in young children. 
  • Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. 
  • Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. 
  • Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program. 
  • Non-parametric estimation for the difference or ratio of median failure times for paired observations. 
  • P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. 
  • Predictors of response to tiotropium versus salmeterol in asthmatic adults. 
  • Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. 
  • Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. 
  • Safety of a peanut oral immunotherapy protocol in children with peanut allergy. 
  • Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients. 
  • Signal transduction. Bringing channels closer to the action! 
  • Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. 
  • The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. 
  • The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. 
  • The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. 
  • Tiotropium bromide step-up therapy for adults with uncontrolled asthma. 
  • Treatment of hyperkalaemia using intravenous and nebulised salbutamol. 
  • Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. 
  • Using Hyperpolarized 129Xe MRI to Quantify the Pulmonary Ventilation Distribution. 
  • β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.